meropenem-FL058

meropenem-FL058 · Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for meropenem-FL058, covering 2021-09-29 to 2021-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections [Phase 2]